Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Geron (GERN) Cash & Equivalents: 2009-2024

Historic Cash & Equivalents for Geron (GERN) over the last 16 years, with Dec 2024 value amounting to $79.0 million.

  • Geron's Cash & Equivalents rose 29.45% to $78.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $78.1 million, marking a year-over-year increase of 29.45%. This contributed to the annual value of $79.0 million for FY2024, which is 12.84% up from last year.
  • Geron's Cash & Equivalents amounted to $79.0 million in FY2024, which was up 12.84% from $70.0 million recorded in FY2023.
  • In the past 5 years, Geron's Cash & Equivalents registered a high of $79.0 million during FY2024, and its lowest value of $9.9 million during FY2020.
  • Its 3-year average for Cash & Equivalents is $68.6 million, with a median of $70.0 million in 2023.
  • Per our database at Business Quant, Geron's Cash & Equivalents fell by 27.26% in 2020 and then skyrocketed by 251.35% in 2021.
  • Over the past 5 years, Geron's Cash & Equivalents (Yearly) stood at $9.9 million in 2020, then spiked by 251.35% to $34.9 million in 2021, then soared by 63.02% to $56.8 million in 2022, then climbed by 23.18% to $70.0 million in 2023, then climbed by 12.84% to $79.0 million in 2024.